Next-generation sequencing (NGS) is a powerful, high-throughput technology that enables rapid and comprehensive analysis of genetic material, offering unparalleled sensitivity for detecting known and unknown contaminants, verifying product integrity, and supporting regulatory compliance.
Intended for vaccine manufacturers in countries with low- and middle-income economies, this two-day webinar will provide up-to-date information and guidance from subject matter experts on NGS methodology, validation, regulatory expectations, and controls. This session will also provide real-world NGS application in the form of two case studies and will end with a panel discussion featuring regulatory experts.
Dates:
- Part 1: 6-9 AM EDT, September 17, 2025
- Part 2: 6-9 AM EDT, September 18, 2025
Speakers include:
- Kutub Mahmood, PhD, PATH
- Tara Tagmyer, PhD, PATH
- Colette Cote, PhD, Pathoquest
- Bradley Hasson, MBA, Millipore Sigma
- Leyla Diaz, PhD, Millipore Sigma
- Arifa Khan, PhD, US FDA
- Konstantin Chumakov, PhD, George Washington University
- Representatives from country regulatory authorities
Please register for the webinar here.